N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD
Clinical trial NCT05706402 · UNKNOWN
Trial details
- NCT number
- NCT05706402
- Sponsor
- Queen Mary Hospital, Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2025-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.